Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Phase IIb study of RPL-554 in COPD meets primary endpoint

March 26, 2018

New phase II trial explores SAR-440340 alone and with dupilumab for moderate to severe asthma

March 23, 2018

Inhaled JAK1 inhibitors synthesized for treating asthma

March 22, 2018

SAR-191801, an orally active inhibitor of H-PGDS for asthma and COPD

March 22, 2018

Expanded indication accepted in E.U. for Spiriva Respimat

March 20, 2018

FDA grants fast track designation to nintedanib for SSc-ILD

March 20, 2018

Merck Sharp & Dohme initiates phase III trial of gefapixant in adults with chronic cough

March 20, 2018

Novartis patents novel CFTR modulators

March 16, 2018

FDA grants orphan drug designation to Proteostasis Therapeutics' PTI-428

March 16, 2018

Avillion enters agreement to develop PT-027 for asthma

March 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...